Description

Tesamorelin & Ipamorelin Peptide Blend

Optimize Growth Hormone, Metabolism & Muscle Health

The Tesamorelin and Ipamorelin blend combines two peptides that may synergistically stimulate the growth hormone axis. Tesamorelin, a GHRH analog, and Ipamorelin, a GHSR agonist, appear to target distinct mechanisms in the pituitary gland to enhance endogenous growth hormone release. This peptide combination is potentially beneficial for optimizing sleep, metabolic function, cognition, lean mass, and lipid profiles in research models.

---

How the Blend Works

By activating complementary pathways, Tesamorelin and Ipamorelin may improve GH secretion, support lipolysis, enhance insulin sensitivity, and boost IGF-1 levels. This dual action may positively influence body composition, visceral fat reduction, muscle density, and bone health. Researchers suggest this blend could also enhance gastric function, regulate appetite, and promote energy balance through ghrelin receptor activity.

---

Research Applications

Growth Hormone & Pituitary Activation

Tesamorelin targets GHRH receptors, while Ipamorelin activates GHSR receptors. Together, they may increase growth hormone output by over 60-fold compared to controls, supporting research into hormone optimization.

Metabolic Support & Lipodystrophy

The blend may reduce visceral adipose tissue, improve triglycerides, and enhance insulin sensitivity. Studies suggest it may provide complementary benefits for metabolic disorders and T2DM research.

Muscle & Bone Health

Research indicates potential improvements in muscle density, skeletal muscle robustness, and bone mineral content. Tesamorelin and Ipamorelin may promote protein synthesis and IGF-1 signaling pathways, enhancing overall tissue integrity in lab models.

Cognitive and Sleep Research

The peptides may support neuroplasticity, memory, and learning through growth hormone-mediated pathways. The combination is also associated with improved deep sleep quality and overall cognitive function.

Appetite, Digestion & Energy Balance

Ipamorelin interacts with ghrelin receptors to potentially modulate appetite and improve gastric emptying, offering a model to study digestive and energy metabolism in laboratory research.

---

Chemical Makeup

• Tesamorelin Molecular Formula: C221H366N72O67S

• Tesamorelin Molecular Weight: 5136 g/mol

• Ipamorelin Molecular Formula: C38H49N9O5

• Ipamorelin Molecular Weight: 711.8 g/mol

• Other Names: (Tesamorelin) (3E)-hex-3-enoylsomatoliberin, (Ipamorelin) Ipamorelin Acetate, Aib-His-D-2-Nal-D-Phe-Lys-NH2

---

visit our Contact page for any inquiry

References:

1. Adrian S, Scherzinger A, Sanyal A, Lake JE, Falutz J, Dubé MP, Stanley T, Grinspoon S, Mamputu JC, Marsolais C, Brown TT, Erlandson KM. The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV. J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. PMID: 31237318; PMCID: PMC6766405. https://pubmed.ncbi.nlm.nih.gov/31237318/
2. Clemmons DR, Miller S, Mamputu JC. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One. 2017 Jun 15;12(6):e0179538. doi: 10.1371/journal.pone.0179538. PMID: 28617838; PMCID: PMC5472315. https://pubmed.ncbi.nlm.nih.gov/28617838/
3. National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 16137828, Tesamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin